Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy: A Randomized Placebo-controlled Double-blinded Trial

NCT03008421 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03008421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03008421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy: A Randomized Placebo-controlled Double-blinded Trial
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2018
Completion date
December 16, 2019
Enrollment
1,058 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbs, neonatal sepsis, pregnancy complications, vaginal infection